On November 17, 2020 PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, reported that the Company will host a Virtual Life Science Event for the investment community on Thursday, December 10 at 8:30 a.m. ET (Press release, PerkinElmer, NOV 17, 2020, View Source [SID1234571229]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

This event is organized to serve as an in-depth breakdown of the Company’s business serving Life Science End Markets, including its portfolio, strategy, latest innovations and scientific advances. Speakers will include Jamey Mock, SVP and chief financial officer of PerkinElmer, Alan Fletcher, VP and GM of PerkinElmer Life Sciences, Kevin Willoe, VP and GM of PerkinElmer Informatics, and Gary Grecsek, VP and GM of PerkinElmer Enterprise Services.

A live audio webcast will be available on the Investors section of the Company’s website at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer website after the event and will be available for 90 days following.